RSV Vaccine Response in Stem Cell and CAR-T Therapy Recipients

Clinical trial NCT07296120 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07296120
Sponsor: The Cooper Health System
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

CAR-T Cell Therapy RSV Immunization Bone Marrow Transplant - Autologous or Allogeneic

Start date: 2026-01-01
Primary completion: 2027-01-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.